We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Tekmira Presents Positive Interim Results on Phase I/II Clinical Programs

News   May 23, 2014

 
Tekmira Presents Positive Interim Results on Phase I/II Clinical Programs
 
 
 

RELATED ARTICLES

Unraveling the Genetic Secrets of the Glacier Ice Worm

News

Researchers uncover factors underlying the genetic structure of glacier ice worms.

READ MORE

Clinical Trial Assessing Treatments for Preventing People at High Risk From Developing Multidrug-resistant TB Launches

News

A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis (MDR-TB) has begun. The study is comparing the safety and efficacy of a new MDR-TB drug, delamanid, with the decades-old TB drug isoniazid for preventing active MDR-TB disease in children, adolescents and adults at high risk who are exposed to adult household members with MDR-TB.

READ MORE

Embryonic Stem Cells Commit to Their Fate Earlier Than First Thought

News

This study challenges the longstanding assumption that embryonic stem cells remain quite plastic and malleable during the earliest stages of cell commitment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE